Anticancer immune cells, for instance, activated B cells, NK cells, dendritic cells, and CD8 T cells, were evidently higher in the low-risk group compared with the high-risk group, which led to the stronger anticancer response and clearance of cancer cells. Here, CD8A is linked to cancer.